Bend Research signs technology licensing agreement with Merck


Merck gains access to spray dried dispersion technology

Bend Research, a US drug-formulation development and manufacturing firm, has signed a licensing agreement with Merck, through a subsidiary.

Under the terms of the agreement, Bend Research will provide Merck with access to its proprietary spray dried dispersion (SDD) technology.

The Bend, Oregon-based firm may also give Merck access to other drug-delivery platforms and intellectual property, including modified-release technologies and drug-discovery formulation tools.

Under the agreement, the two firms will use their scientific and engineering capabilities to solve complex formulation and process-development problems with a view to transferring these solutions to a cGMP environment.